Wei‐Ting Shen

895 total citations · 1 hit paper
21 papers, 666 citations indexed

About

Wei‐Ting Shen is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Wei‐Ting Shen has authored 21 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomedical Engineering, 7 papers in Molecular Biology and 5 papers in Biomaterials. Recurrent topics in Wei‐Ting Shen's work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (5 papers) and Extracellular vesicles in disease (4 papers). Wei‐Ting Shen is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (5 papers) and Extracellular vesicles in disease (4 papers). Wei‐Ting Shen collaborates with scholars based in United States, Taiwan and Japan. Wei‐Ting Shen's co-authors include Li‐Han Lin, Nai‐Wen Liang, Yi‐Hsuan Lin, Katalin V. Korpany, John J. Hill, James J. Lai, Joanne Kimiko Liu, Yu‐Chung Liu, Shang‐Hsiu Hu and Weiwei Gao and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Wei‐Ting Shen

18 papers receiving 658 citations

Hit Papers

Exosome Processing and Characterization Approaches for Re... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Ting Shen United States 10 427 192 192 84 68 21 666
Miao Fan China 12 229 0.5× 80 0.4× 345 1.8× 118 1.4× 71 1.0× 19 632
Chenglong Ge China 13 366 0.9× 50 0.3× 158 0.8× 137 1.6× 107 1.6× 27 649
Alba Nicolás‐Boluda France 16 326 0.8× 139 0.7× 362 1.9× 182 2.2× 168 2.5× 27 935
Yunan Zhao China 13 239 0.6× 64 0.3× 158 0.8× 105 1.3× 116 1.7× 39 660
Nisakorn Yodsanit United States 11 257 0.6× 30 0.2× 246 1.3× 122 1.5× 32 0.5× 17 602
Zihuang Li China 17 269 0.6× 126 0.7× 220 1.1× 122 1.5× 45 0.7× 39 665
Hailiang Deng China 8 289 0.7× 75 0.4× 139 0.7× 146 1.7× 74 1.1× 9 540
Ziyi Mai China 11 140 0.3× 56 0.3× 286 1.5× 94 1.1× 108 1.6× 12 456
Pengyu Guo China 11 242 0.6× 154 0.8× 127 0.7× 46 0.5× 44 0.6× 23 499

Countries citing papers authored by Wei‐Ting Shen

Since Specialization
Citations

This map shows the geographic impact of Wei‐Ting Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ting Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ting Shen more than expected).

Fields of papers citing papers by Wei‐Ting Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Ting Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ting Shen. The network helps show where Wei‐Ting Shen may publish in the future.

Co-authorship network of co-authors of Wei‐Ting Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Ting Shen. A scholar is included among the top collaborators of Wei‐Ting Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Ting Shen. Wei‐Ting Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhengxing, Dan Wang, Hao Luan, et al.. (2025). Picoeukaryote-based biohybrid microrobots for active delivery in the kidney. Science Advances. 11(28). eadw8578–eadw8578.
2.
Sun, Lei, et al.. (2025). Controlled Dimerization of Cellular Nanodiscs via Click Chemistry to Enhance Immune Compatibility. Journal of the American Chemical Society. 147(33). 30136–30145. 1 indexed citations
3.
Shen, Wei‐Ting, et al.. (2025). Recent Development of Nanoparticle Platforms for Organophosphate Nerve Agent Detoxification. Langmuir. 41(4). 2124–2140. 4 indexed citations
4.
Sun, Lei, et al.. (2025). Pharmacological Mechanisms of Cellular Nanoparticles in Biological Neutralization. The Annual Review of Pharmacology and Toxicology. 66(1). 211–225.
5.
Sun, Lei, Yiyan Yu, Wei‐Ting Shen, et al.. (2025). Hepatic endoplasmic reticulum-derived nanodiscs for broad-spectrum drug detoxification. Biomaterials. 318. 123188–123188. 2 indexed citations
6.
Yu, Yiyan, Yifei Peng, Wei‐Ting Shen, et al.. (2024). Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications. SHILAP Revista de lepidopterología. 5(5). 27 indexed citations
7.
Wang, Dan, Lei Sun, Wei‐Ting Shen, et al.. (2024). Neuronal Membrane-Derived Nanodiscs for Broad-Spectrum Neurotoxin Detoxification. ACS Nano. 18(36). 25069–25080. 6 indexed citations
8.
Shen, Wei‐Ting, Yiyan Yu, Dan Wang, et al.. (2024). Dual-Modal Cellular Nanoparticles for Continuous Neurotoxin Detoxification. Nano Letters. 24(24). 7515–7523. 4 indexed citations
9.
Li, Zhengxing, Yaou Duan, Fangyu Zhang, et al.. (2024). Biohybrid microrobots regulate colonic cytokines and the epithelium barrier in inflammatory bowel disease. Science Robotics. 9(91). eadl2007–eadl2007. 40 indexed citations
10.
Shen, Wei‐Ting, et al.. (2024). Research Advances of Cellular Nanoparticles as Multiplex Countermeasures. ACS Nano. 18(44). 30211–30223. 13 indexed citations
11.
Shen, Wei‐Ting, Dan Wang, Yiyan Yu, et al.. (2024). Aptamer‐Encapsulated Cellular Nanoparticles for Neurotoxin Neutralization. Advanced Healthcare Materials. 14(2). e2403539–e2403539. 3 indexed citations
12.
Shen, Wei‐Ting, Chien‐Wen Chang, Wen‐Hsuan Chiang, et al.. (2023). Programmed T cells infiltration into lung metastases with harnessing dendritic cells in cancer immunotherapies by catalytic antigen-capture sponges. Journal of Controlled Release. 360. 260–273. 22 indexed citations
13.
Wang, Shuyan, Dan Wang, Wei‐Ting Shen, et al.. (2023). Design Strategies for Cellular Nanosponges as Medical Countermeasures. SHILAP Revista de lepidopterología. 4. 18–18. 10 indexed citations
14.
Wang, Shuyan, Dan Wang, Wei‐Ting Shen, et al.. (2023). Protein‐Loaded Cellular Nanosponges for Dual‐Biomimicry Neurotoxin Countermeasure. Small. 20(14). e2309635–e2309635. 3 indexed citations
15.
Shen, Wei‐Ting, et al.. (2021). Advances in Functional Metal‐Organic Frameworks Based On‐Demand Drug Delivery Systems for Tumor Therapeutics. Advanced NanoBiomed Research. 1(8). 9 indexed citations
16.
Shen, Wei‐Ting, et al.. (2021). Advances in Functional Metal‐Organic Frameworks Based On‐Demand Drug Delivery Systems for Tumor Therapeutics. SHILAP Revista de lepidopterología. 1(8). 32 indexed citations
17.
Hsu, Ru-Siou, Jen‐Hung Fang, Wei‐Ting Shen, et al.. (2020). Injectable DNA-architected nanoraspberry depot-mediated on-demand programmable refilling and release drug delivery. Nanoscale. 12(20). 11153–11164. 8 indexed citations
18.
Shen, Wei‐Ting, et al.. (2020). Marginative Delivery-Mediated Extracellular Leakiness and T Cell Infiltration in Lung Metastasis by a Biomimetic Nanoraspberry. Nano Letters. 21(3). 1375–1383. 38 indexed citations
19.
Shen, Wei‐Ting & Hsin‐Ning Su. (2016). Evaluating the use of patent family for understanding globalized industrial innovation. 1506–1514.
20.
Chu, Jean‐Ho, et al.. (2011). Palladium(II)‐Catalyzed One‐Pot Syntheses of 9‐(Pyridin‐2‐yl)‐9H‐carbazoles through a Tandem CH Activation/CX (X=C or N) Formation Process. Chemistry - A European Journal. 17(48). 13613–13620. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026